Roswitha Kammler
- Oncology top 10%
- Genetics top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Pharmacology top 2%
- Co-authors
- Giuseppe VialeMeredith M. ReganBeat ThürlimannMarco ColleoniRudolf MaibachRichard D. GelberAron GoldhirschPatrizia Dell’Orto
- Topics
- Breast Cancer Treatment Studies (11 papers)Lung Cancer Treatments and Mutations (8 papers)Cancer Genomics and Diagnostics (7 papers)
- Cited by
- PharmacologyOncologyCancer Research
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Roswitha Kammler
26 papers receiving 706 citations
Peers
Comparison fields: 5 of 56
- Oncology 444
- Genetics 263
- Pulmonary and Respiratory Medicine 231
- Cancer Research 212
- Pharmacology 185
Countries citing papers authored by Roswitha Kammler
This map shows the geographic impact of Roswitha Kammler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roswitha Kammler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roswitha Kammler more than expected).
Fields of papers citing papers by Roswitha Kammler
This network shows the impact of papers produced by Roswitha Kammler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roswitha Kammler. The network helps show where Roswitha Kammler may publish in the future.
Co-authorship network of co-authors of Roswitha Kammler
This figure shows the co-authorship network connecting the top 25 collaborators of Roswitha Kammler. A scholar is included among the top collaborators of Roswitha Kammler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roswitha Kammler. Roswitha Kammler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 7 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 107 | |
| 11 | 90 | |
| 12 | 1 | |
| 13 | 7 | |
| 14 | 20 | |
| 15 | Phase Ib/II study evaluating safety and efficacy of Pembrolizumab and Trastuzumab in patients with Trastuzumab-resistant HER2-positive advanced breast cancer : results from the PANACEA study (IBCSG 45-13/BIG 4-13/KEYNOTE-014) | 5 |
| 16 | 1 | |
| 17 | 21 | |
| 18 | 90 | |
| 19 | 7 | |
| 20 | 229 |
About Roswitha Kammler
Roswitha Kammler is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 721 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Pharmacology (185 citations), Oncology (444 citations) and Cancer Research (212 citations). Roswitha Kammler has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Giuseppe Viale, Meredith M. Regan, Beat Thürlimann, Marco Colleoni, Rudolf Maibach, Richard D. Gelber, Aron Goldhirsch, Patrizia Dell’Orto, Karen N. Price and Olivia Pagani. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.